FIRST-IN-HUMAN PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND INITIAL CLINICAL ACTIVITY OF DUOBODY (R)-CD40x4-1BB (GEN1042) IN PATIENTS WITH ADVANCED SOLID TUMORS
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要